Floatz logo

PHENPROCOUMON

Myocardial Infarction

St. Antonius HospitalSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Myocardial Infarction cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Shanghai CureGene Pharmaceutical Co., Ltd.
Phase 4A
Plavix
Shanghai CureGene Pharmaceutical Co., Ltd.
Phase 4A
Ticagrelor
Assistance Publique - Hôpitaux de Paris
Phase 4BBB
Folic Acid
Hamilton Health Sciences Corporation
Phase 4BBB
Vitamin B6
Hamilton Health Sciences Corporation
Phase 4BBB

View all 40 →

Same molecule, other indications

PHENPROCOUMON is also rated in:

Aortic Valve StenosisDormant
BB
Indicative ·
69 / 100
View asset →
Aortic Valve DiseaseDormant
BB
Indicative ·
69 / 100
View asset →
Vascular ComplicationsDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →